Jul 25 |
DexCom (DXCM) Q2 Earnings Surpass Estimates
|
Jul 25 |
Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut
|
Jul 25 |
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
|
Jul 25 |
DexCom drops 33% following updated revenue estimates
|
Jul 25 |
Earnings Summary: DexCom delivers mixed Q2, full-year revenue forecast falls short of estimates
|
Jul 25 |
DexCom: Q2 Earnings Snapshot
|
Jul 25 |
DexCom Non-GAAP EPS of $0.43 beats by $0.04, revenue of $1B misses by $40M
|
Jul 25 |
Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
|
Jul 25 |
Dexcom cuts guidance as Q2 revenue falls short of estimates; shares slump
|
Jul 25 |
At US$112, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?
|